Division of Molecular Medicine and Gene Therapy

Organisational unit: Division


Dysfunctional blood cell development can have fatal consequences on human health, with implications for several key areas of modern medicine, including amongst others the broad research areas of oncology and immunology. The Division of Molecular Hematology (DMH) aims to generate new knowledge about the regulation of blood cell development by applying recent advances in stem cell technology, in order to dissect the molecular regulation of hematopoiesis. Our mission is to translate this information into clinical contexts to advance the full potential of regenerative medicine.


The department focuses on research that aims to develop gene therapy for hematopoietic cells using viral vectors. Hematopoiesis, in particular the genetic control of hematopoietic cell proliferation and differentiation is also studied in human cell cultures and transgenic mouse model systems.

Recent research outputs

Zahra Masoumi, Maes, G. E., Herten, K., Cortés-Calabuig, Á., Abdul Ghani Alattar, Hanson, E., Lena Erlandsson, Mezey, E., Mattias Magnusson, Vermeesch, J. R., Mary Familari & Stefan R. Hansson, 2019 Apr 25, In : International Journal of Molecular Sciences. 20, 8, 2038.

Research output: Contribution to journalArticle

Kumar, P., Beck, D., Roman Galeev, Thoms, J. A. I., Mehrnaz Safaee Talkhoncheh, de Jong, I., Unnikrishnan, A., Aurélie Baudet, Agatheeswaran Subramaniam, Pimanda, J. E. & Jonas Larsson, 2019 Feb 26, In : Blood Advances. 3, 4, p. 681-691 11 p.

Research output: Contribution to journalArticle

View All (397)